Related Experiment Video
Updated: Feb 11, 2026

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
Published on: June 20, 2020
A pilot single arm observational study of sofosbuvir/ledipasvir (200 + 45 mg) in 6- to 12- year old children
M H F El-Shabrawi1, N M Kamal1, H R El-Khayat2
1Pediatric Hepatology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Insights
This study shows that a fixed dose of sofosbuvir/ledipasvir is safe and effective for treating chronic hepatitis C genotype 4 in children aged 6-12 years. All participants achieved sustained virological response without side effects.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Infectious Diseases
Background:
- Limited data exists on sofosbuvir/ledipasvir for treating hepatitis C virus (HCV) in children aged 6-12.
- Chronic HCV infection in pediatric populations requires safe and effective treatment options.
Purpose of the Study:
- To evaluate the safety and efficacy of sofosbuvir/ledipasvir in children aged 6-12 with chronic HCV genotype 4.
- To establish optimal dosing for pediatric HCV treatment.
Main Methods:
- Pilot prospective, single-arm, observational, open-label, multicenter study.
- 20 children (6-12 years) with chronic HCV genotype 4 received a fixed sofosbuvir/ledipasvir dose (200/45 mg) daily for 12 weeks.
- Virological markers and safety assessments were conducted throughout treatment and for 12 weeks post-treatment for sustained virological response (SVR12).
Main Results:
- The intention-to-treat SVR12 rate was 95% (19/20 children).
- 100% of patients who completed the study (19/19) achieved SVR12.
- No side effects or fatalities were reported; liver, hematological, and renal function tests remained normal.
Conclusions:
- The fixed dose of sofosbuvir/ledipasvir is a safe and effective treatment for chronic hepatitis C genotype 4 in children aged 6-12 years.
- These findings support larger multicenter studies to confirm efficacy in this pediatric age group.
Background:
No available data on the use of sofosbuvir/ledipasvir combination in treatment of hepatitis C virus (HCV) infection in children 6- to 12- year old.
Aim:
To assess the safety and efficacy of sofosbuvir plus ledipasvir in children 6- to 12- year old with chronic HCV genotype 4 infection.
Methods:
This is a pilot prospective single arm observational open-label multicentre study. A total of 20 consecutive eligible chronic HCV infected children, aged from 6- to 12- years were included in this study and treated with a fixed sofosbuvir/ledipasvir combination in half the adult dose (200/45 mg) once daily for 12 weeks. Laboratory tests including virological markers were measured at baseline, 2, 4, 8 and 12 weeks (end of treatment [EOT]), and 12 weeks after end of treatment for sustained virological response 12 (SVR12).
Results:
The intention-to-treat (ITT) SVR12 rate was 19/20 (95%; 95% CI: 76.4%-99.1%). SVR12 was not assessed in one patient who was lost to follow-up after showing viral negativity at the EOT12. All the remaining 19 patients (100%, 95% CI: 83.18%-100%) who completed the full protocol and follow-up visits achieved SVR12 with normal liver, haematological, and renal function tests and no side effects or fatalities.
Conclusions:
This pilot study demonstrated that the fixed dose sofosbuvir/ledipasvir combination could be safe and effective treatment in children 6- to 12- years with chronic hepatitis C genotype 4 infection. Our pilot results might encourage larger and multicentre studies in this age group.
More Related Videos
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
08:40Quantifying Arms and Legs Contributions during Repetitive Electrically-Assisted Sit-To-Stand Exercise in Paraplegics: A Pilot Study
Published on: November 11, 2022
Related Concept Videos
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
Pilot and Numeric Relaying
Muscles that Move the Arm
The pectoralis major has two origins. Its clavicular head originates on the medial half of the clavicle. In contrast, the sternocostal head originates on the costal cartilages of ribs 1-6, the sternum, and the aponeurosis of the external oblique of the...
Naturalistic Observations
Bioavailability Study Design: Single Versus Multiple Dose Studies
Observational Learning